Randomized open label phase III trial of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane: Proceed trial (KCSG BR 11-01)

In Hae Park, Seock Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee Jun Kim, Tae Yong Kim, Kyung Hun Lee, Sung Bae Kim, Jin Hee Ahn, Suee Lee, Jungsil Ro

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Randomized open label phase III trial of irinotecan plus capecitabine versus capecitabine monotherapy in patients with metastatic breast cancer previously treated with anthracycline and taxane: Proceed trial (KCSG BR 11-01)'. Together they form a unique fingerprint.

Medicine & Life Sciences